🩺 69Fun Clinical Endocrinology Suite ✓ MD Fact-Checked ✓ AMA & ICMJE Guidelines ✓ 100% Client-Side Privacy
⚡ 15 Health Tools → | 🤖 Ask 69Fun AI

Thyroid & GLP-1 Weight Loss Medication Calculator

Incretin Pharmacokinetics
Semaglutide / Tirzepatide Safety
Weight-Based T4 Recalibration

Thyroid & GLP-1 Weight Loss Medication Calculator

Evaluate gastric emptying delays and automatically recalibrate daily levothyroxine dosage as body mass drops during Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro/Zepbound) therapy.




GLP-1 Recalibration Output

Weight-Based T4 Pharmacokinetics + Gastric Motility Advisory

Dose Reduction Likely Needed

134 mcg/day
Projected Need Based on Weight Loss

Delayed Gastric Emptying Warning

GLP-1 receptor agonists substantially slow gastric emptying. Solid levothyroxine tablets may take longer to reach the small intestine; consider switching to liquid or softgel levothyroxine if your TSH becomes erratic.


WhatsApp

🔬

Peer-Reviewed Clinical Sources & Institutional Evidence

Cross-referenced against verified endocrine consensus guidelines and medical registries

To ensure diagnostic accuracy, pharmacovigilance, and patient safety, all content on 69Fun Health & Thyroid Suite is strictly cross-referenced against primary clinical literature and high-authority institutional medical databases:

🏛
PubMed / NCBI (NIH) →
National Library of Medicine • Index of 36M+ Peer-Reviewed Studies
📋
American Thyroid Association →
Official Practice Guidelines for Hypothyroidism & Nodules
🩺
The Endocrine Society →
Global Clinical Practice Consensus for Thyroid & Hormones
🏥
Mayo Clinic Endocrine Center →
Clinical Diagnostics & Levothyroxine Protocol Database
🏦
Cleveland Clinic Endocrinology →
Thyroid Pathology & Autoimmune Clinical Guidelines
🌍
World Health Organization →
Global Micronutrient & Iodine Nutrition Standards
Editorial Team: 69Fun Health Editors • Editorial Director: 69Fun Editorial Team
✔ ICMJE & AMA Ethical Guidelines
🏠 Home ⚡ 15 Tools 🩺 Screener 📚 Topics 🤖 AI Doctor